Regional Digestive System Neuroendocrine Tumor G1

Regional Digestive System Neuroendocrine Tumor G1 — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00454363	Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer	completed	Phase 2	52	National Cancer Institute (NCI)NIH	1	Apr 3, 2020	clinicaltrials
NCT01010126	Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer	completed	Phase 2	252	National Cancer Institute (NCI)NIH	2	Jan 25, 2019	clinicaltrials
NCT00055809	Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors	completed	Phase 2	44	National Cancer Institute (NCI)NIH	1	Jan 23, 2013	clinicaltrials

Data updated 22 days agoSource updated Apr 3, 2020source: clinicaltrials